Navigation Links
Dealing with personality disorders

The drug fluvoxamine has been found by researchers to be more effective than placebos in treating rapid mood shifts in women with borderline personality disorder. This study , which included 38 non-schizophrenic, non-bipolar women with borderline// personality disorder between the ages of 19 and 51 was conducted by researchers from various universities in Netherlands. They were evaluated for differences in rapid mood shift, impulsivity and aggression when given fluvoxamine or a placebo.

Participants were first randomly and unknowingly given fluvoxamine or a placebo for six weeks. This was followed by another six weeks in which all of the participants were given fluvoxamine. Again, it was unknown to the participants if they had been given the drug or the placebo. Researchers then gave the participants fluvoxamine for 12 weeks and told the participants they were receiving the drug.

Researchers reported that fluvoxamine generated a healthy and long lasting decrease in rapid mood shifts, but the placebo did not. It was also found that the drug did not have any impact on impulsivity and aggression. This authors say, may be due to gender-specific differences in impulsivity and aggression. Prior to this study, selective serotonin reuptake inhibitors, called SSRIs were prescribed for treatment of borderline personality disorder symptoms.


'"/>




Page: 1

Related medicine news :

1. Dealing heart disease risk in ethnic minorities
2. Dealing With Stress Results In Better Academic Performance
3. CMHA Calls For Better Trained Police For Dealing With The Mentally Ill
4. Dealing With Nausea When Pregnant
5. Dealing with IBS
6. Individuals with sleep related breathing disorders more prone to heart disease
7. Eating disorders are hereditary
8. Low testosterone levels lead to eating disorders
9. Heriditary dental disorders
10. Sleep disorders can have anomalistic sexual acts
11. Exercise with music aids with lung disorders
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Dealing with personality disorders

(Date:12/2/2008)...EAK to collect and disseminate pharmacy experience...ue, Wash. (PRWEB) December 2, 2008 -- Pharmacy On... initiative to focus public and industry attention...ck-off of SPEAK will occur during the American Soc...ear Clinical Meeting, to be held December 7-11 in ...
(Date:12/2/2008)... this year,s ASHP midyear meeting, FFF Enterprises...r of critical-care biopharmaceuticals and vaccines...chain integrity and demonstrate how the company ha.... (Booth #1439) , (Vocus)...eeting, FFF Enterprises, the nation,s largest and ...
(Date:12/2/2008)... the International Day of Disabled Persons is reco...story of a young boy born with backwards pointing ...y, a floating hospital docked in Liberia, Benedict...with the other children his age. High resolution...hipsnewsroom.org , Garde...
(Date:12/2/2008)...ar Unafraid: Learning to Trust No Matter What by J...2008 Awards.,In 1977, strange symptoms assaulted ... with multiple sclerosis. Jo had backpacked up 14,...ty miles an hour. , Battl...raid: Learning to Trust No Matter What by Jo Franz...
Breaking Medicine News(10 mins):Health News:Pharmacy OneSource Launches SPEAK Initiative to Promote Medication Safety Awareness 2Health News:FFF Enterprises Unveils ‘The 8 Critical Steps to Guaranteed Channel Integrity' at the American Society of Health-System Pharmacists (ASHP) Midyear Meeting in Orlando 2Health News:FFF Enterprises Unveils ‘The 8 Critical Steps to Guaranteed Channel Integrity' at the American Society of Health-System Pharmacists (ASHP) Midyear Meeting in Orlando 3Health News:Mercy Ships Recognizes International Day of Disabled Persons 2Health News:Mercy Ships Recognizes International Day of Disabled Persons 3Health News:Nothing Has Stopped This Woman--MS, Divorce, Abuse, Trauma--How to Live Adventurously and Fearlessly No Matter What Happens 2Health News:Nothing Has Stopped This Woman--MS, Divorce, Abuse, Trauma--How to Live Adventurously and Fearlessly No Matter What Happens 3
...ttent treatment with sulfadoxine-pyrimethamine, a ... in treating malaria in Mozambican children //by R...edro Alonso, coordinator of the Centre of Internat... findings of their study are to be published in th...
...e backdrop of questions being raised about its aut...of making the All India Institute of Medical Scien...ies". "We hope we can come out with some recommen...e as possible from authorities," M S Valiathan, wh...
... live alone are twice as likely to have serious he...s a new study//. According to a study published in... Danish researchers surveyed around 1,38,000 adult... in one area of Denmark and found that certain hea...
...n reported that doctors from the Michigan State Un...treatment plan, which allows a more effective// me...r people suffering from symptoms and conditions th...Smith, a physician and professor in MSU’s Departme...
Other Medicine News:Health News:Intermittent Treatment Found Effective In Malaria 2Health News:Intermittent Treatment Found Effective In Malaria 3Health News:Intermittent Treatment Found Effective In Malaria 4Health News:Intermittent Treatment Found Effective In Malaria 5Health News:Revolutionary New Treatment Plan Developed For Treatment Of Unexplained Symptoms 2
(Date:11/25/2008)...Nov. 25 Proteolix, Inc., a,leader...utics that target,protein degradation pathways in...that data from two ongoing Phase 2 clinical trials...nted at the upcoming 50th Annual Meeting of the,A...is the first in a new class,of specific proteasom...
(Date:11/25/2008)...ical Trial to Assess Survival of Patients Receivin...ectable Hepatocellular Carcinoma , , BELLEV...Oncology, Inc. (LSO) today announced the completio... of Light Infusion Therapy(TM) (Litx(TM)) as a tre...HCC), also known as hepatoma or primary liver canc...
(Date:11/24/2008)...Newswire/ -- Domino,s Pizza (NYSE: DPZ ), the,r...ng up to raise dough for,the kids of St. Jude Chi...,Thanks and Giving campaign. Domino,s customers wi...nt of purchase to benefit the children of St. Jude...one or when ordering online at, www.dominos.com ....
(Date:11/24/2008)...ion leadership and long-term commitment to hepatit...PRNewswire-FirstCall/ -- Schering-Plough Corporati... on boceprevir, its lead investigational oral hepa...development. The company believes boceprevir has ...lass protease inhibitor for treating chronic hepat...
Breaking Medicine Technology:Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 2Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 4Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 6Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 7Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 8Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 9Gene Mutation Puts Some Kids at Risk for Tobacco Addiction 24151 1Gene Mutation Puts Some Kids at Risk for Tobacco Addiction 24151 2U S Health Care Still Ill Survey Finds 24149 1U S Health Care Still Ill Survey Finds 24149 2U S Health Care Still Ill Survey Finds 24149 3Aethons Train Themed Delivery Robot Available To Childrens Hospitals Nationwide 24147 1Aethons Train Themed Delivery Robot Available To Childrens Hospitals Nationwide 24147 2WeissComm Partners Ranks Among Top 5 Best U S Midsize PR Agencies to Work For 24145 1WeissComm Partners Ranks Among Top 5 Best U S Midsize PR Agencies to Work For 24145 2
...ased, 2-8-channel system for measuring bioelectric...optic nerve. The basic set comprises: computer dev...ioelectrical amplifier, electrodes and checkerboar...o install. The recorded curves are displayed on a ...
A sophisticated research tool that allows to see the fundus picture of the area which is being stimulated. Besides it also includes the refractive pupil camera enabling the examiner to switch between
5 mm
Cannula and irrigation extension. Overall Length 150 mm (6.25"). Light Curve.
Medicine Products: